Ectopic pregnancy: clinical approach

文摘   科学   2024-07-15 19:12   澳大利亚  
If you would like to view past exciting content, please click on the following link.
Biliary colic-clinical approach
Periumbilical and lower abdominal pain-clinical approach
Upper abdominal pain-clinical approach
Postoperative abdominal pain-clinical approach
Pneumoperitoneum and peritonitis-clinical approach
Abdominal aortic aneurysm-clinical approach
Acute mesenteric ischemia-clinical approach
Acute pancreatitis-clinical approach
Adnexal torsion-clinical approach
Aortic dissection-clinical approach
Appendicitis-clinical approach
Alcohol-induced hepatitis-clinical approach
Chronic mesenteric ischemia-clinical approach
Cholecystitis-clinical approach
Choledocholithiasis and cholangitis-clinical approach
Chronic pancreatitis-clinical approach
Diverticulitis-clinical approach
Colonic volvulus-clinical approach
Colorectal cancer-clinical approach
Gastric cancer-clinical approach
Gastroesophageal reflux disease-clinical approach
Infectious gastroenteritis-clinical approach
Irritable bowel syndrome-clinical approach
Ischemic colitis-clinical approach
Large bowel obstruction-clinical approach
Peptic ulcer disease-clinical approach
Small bowel obstruction-clinical approach
Spontaneous bacterial peritonitis-clinical approach
Inflammatory bowel disease(ulcerative colitis)-clinical approach
Inflammatory bowel disease (Crohn disease)-clinical approach
Major depressive disorder-clinical approach
Bipolar disorder-clinical approach
Fatigue-clinical approach
Hypothyroidism-clinical approach
Trauma- and stress-related disorders-clinical approach
Epstein-Barr virus (Infectious mononucleosis)-clinical approach
Multiple sclerosis-clinical approach
Anorexia nervosa-clinical approach
Bulimia nervosa-clinical approach
Eating disorders-clinical approach
Body dysmorphic disorder
Mood disorders
Schizoaffective disorder
Schizophrenia
Schizophrenia spectrum disorders
Gastroesophageal reflux disease: clinical approach
Schizophrenia spectrum disorders-V2
Hyperthyroidism
Hyperthyroidism-with cases
Hyperthyroidism and thyrotoxicosis-clinical approach
Hyperthyroidism-V2
Central nervous system infections-with cases
Traumatic brain injury-clinical approach
Post-traumatic stress disorder
Peri/menopause/primary ovarian insufficiency: clinical approach
Sleep apnea-clinical approach
Generalized anxiety disorder
Anxiety disorders/phobias/stress-related disorders with cases
Panic disorder
Phobias
Obsessive compulsive disorders
Tobacco use disorder
Epilepsy
Hypoglycemia: clinical approach
Malingering, factitious disorders and somatoform disorders
Stroke
Tachycardia: clinical approach
Wolff-Parkinson-White syndrome
Hypovolemic shock: clinical approach
Opioid intoxication and overdose: clinical approach
Drug misuse/intoxication/withdrawal: some depressants with cases
Delirium: clinical approach
Substance misuse and addiction
Adult brain tumors
Pediatric brain tumors
Chest pain: clinical approach
Infectious endocarditis: clinical approach
Pulmonary embolism: clinical approach
Chronic bronchitis
Community-acquired pneumonia: clinical approach
Hospital-acquired/ventilator-associated pneumonia: clinical appr
Acute coronary syndrome: clinical approach
Coronary artery disease (un/stable angina): clinical approach
Typical antipsychotics
Atypical antipsychotics
Essential tremor
Alcohol withdrawal: clinical approach
Cirrhosis: clinical approach
Hepatic encephalopathy
Beriberi
Orthostatic hypotension
Valvular heart diseases
Somatic symptom disorders
Headache with cases
Polycystic ovary syndrome (PCOS): clinical approach
Hydration
Pregnancy
Parkinson's disease
Dementia with cases
Diabetes mellitus (Type 1): clinical approach
Diabetes mellitus (Type 2): clinical approach
Preconception care: clinical approach
Systemic lupus erythematosus: clinical approach
Antepartum care (first trimester): clinical approach
Antepartum care (second trimester): clinical approach
Antepartum care (third trimester): clinical approach
An ectopic pregnancy occurs when a pregnancy develops outside the uterine cavity. Typically, in an intrauterine pregnancy, embryonic tissue implants within the decidualized endometrium, usually at the top of the uterus. In contrast, during an ectopic pregnancy, this implantation often occurs in the fallopian tube, predominantly in the ampulla, though it can also happen in the isthmus or interstitial parts of the tube. Other less common implantation sites include the abdomen, cervix, or a c-section scar. On rare occasions, an ectopic pregnancy can coexist with an intrauterine pregnancy, which is known as a heterotopic pregnancy.
When evaluating a patient who presents with symptoms indicative of an ectopic pregnancy, the first step is to assess their CABCDE to determine their stability. Since an ectopic pregnancy can rupture at any time, causing significant intraperitoneal hemorrhage, initial management should involve preparing for a possible transfusion of packed red blood cells. Stabilize the patient's airway, breathing, and circulation, consider intubation if clinically necessary, establish IV access, and continuously monitor vital signs.
Next, perform a detailed history and physical examination, and order laboratory tests including CBC, CMP, and hCG, or human chorionic gonadotropin. An ultrasound should be conducted to determine the location of the pregnancy and to check for the presence of free fluid in the abdomen or the pelvic cul-de-sac.
Typically, the patient might report a delayed or missed menstrual period, syncope, abdominal or pelvic pain, and vaginal bleeding. On physical examination, signs of hemodynamic instability such as hypotension and tachycardia, altered mental status, and pale, clammy skin may be observed. Signs of acute abdomen like abdominal tenderness, guarding, and rebound pain might also be present, indicating intraperitoneal bleeding. On pelvic examination, bleeding from the cervical os might be noted. Laboratory tests generally show a positive hCG and possibly anemia, while ultrasound findings might include an empty uterus, free fluid in the abdomen or posterior cul-de-sac, and sometimes an adnexal mass.
Thus, if the patient is of childbearing age, tests positive for hCG, shows free fluid without intrauterine pregnancy, a ruptured ectopic pregnancy should be considered until proven otherwise. For management, start IV fluid resuscitation immediately, prepare for blood transfusion regardless of initial reassuring labs, and quickly obtain a gynecological surgical consultation as surgical removal is necessary for all ruptured ectopic pregnancies, preferably using minimally invasive or laparoscopic techniques unless the patient is extremely unstable. If the patient is Rh-negative, administer Rh immune globulin.
For stable patients, begin with a focused history and physical exam, and conduct a urine hCG pregnancy test. Review potential risk factors for ectopic pregnancy, such as previous ectopic pregnancies, history of pelvic inflammatory disease, or past pelvic or tubal surgeries. Also, consider other conditions that could damage the fallopian tubes, such as endometriosis or a history of ruptured appendicitis, though remember that about half of all ectopic pregnancies occur in patients without known risk factors.
During the physical examination, look for abdominal or pelvic tenderness, bleeding from the cervical os, or adnexal fullness or tenderness. Handle the examination gently to avoid rupturing the ectopic pregnancy. If hCG is negative, explore other diagnoses. However, a positive hCG necessitates suspicion of an ectopic pregnancy.
Next, conduct a quantitative hCG test and a pelvic ultrasound. It’s critical to understand the concept of the discriminatory level in quantitative hCG testing, which is an hCG threshold indicating when a viable intrauterine pregnancy should be detectable via ultrasound. Typically, this threshold is set at an hCG level of 3500. If the hCG level exceeds 3500 and no gestational sac is visible on the ultrasound, this strongly suggests a non-viable pregnancy, which could be either an ectopic pregnancy or an early pregnancy loss.
Here’s how to apply this information: If the hCG level is below 3500 and there is no evidence of an intrauterine pregnancy on the ultrasound, you should repeat the quantitative hCG in 48 hours and the ultrasound in one week to confirm the diagnosis. In a normal pregnancy, the hCG level should increase at a predictable rate, whereas in an abnormal pregnancy, the hCG may rise only slightly or even decrease. It's crucial to monitor these patients closely and advise them to report any symptoms indicative of a ruptured ectopic pregnancy immediately.
Shifting focus, consider a scenario where the hCG level is 3500 or higher, but the ultrasound shows no signs of an intrauterine pregnancy. Instead, the ultrasound may reveal signs of an ectopic pregnancy in the adnexa, such as a gestational sac with or without a yolk sac, an embryo, or a mass with a hypoechoic area distinct from the ovary. The presence of these signs confirms the diagnosis of an ectopic pregnancy.
Here's a key point to remember: Quantitative hCG and ultrasound can both be used individually or in combination to diagnose an ectopic pregnancy. If an adnexal mass is observed in patients with a positive hCG test, even if the level is below 3500, it should be considered an ectopic pregnancy until proven otherwise. The 3500 hCG cutoff is specifically used for stable patients where the pregnancy location is unknown, and the ultrasound does not show an intrauterine pregnancy or an adnexal mass.
Now, a clinical insight: Some ectopic pregnancies may present with a pseudogestational sac, which appears as a hypoechoic sac-like structure within the endometrium on ultrasound. This should not be mistaken for a viable pregnancy. Pseudogestational sacs are typically located centrally within the endometrium, whereas gestational sacs associated with viable pregnancies are usually positioned slightly off-center.
Once an ectopic pregnancy is diagnosed, management options include non-surgical treatment with methotrexate, a folic acid antagonist, or surgical intervention using minimally invasive techniques. The choice between these options depends on the presence of any contraindications to methotrexate, which requires thorough evaluation including CBC, CMP, and blood type and screen.
Absolute contraindications for methotrexate treatment include an intrauterine pregnancy, immunodeficiency, significant anemia, leukopenia or thrombocytopenia, known methotrexate sensitivity, active pulmonary or peptic ulcer disease, liver or kidney dysfunction, breastfeeding, and an inability to adhere to necessary follow-up care. This last point is particularly crucial, as effective management with methotrexate demands reliable patient follow-up.
Relative contraindications for methotrexate include observed embryonic cardiac activity, an initial hCG level above 5000, an ectopic pregnancy measuring more than 4 cm on transvaginal ultrasound, and patient refusal to accept a blood transfusion.
When assessing contraindications, if absolute contraindications are present, surgical management is necessary. If only relative contraindications exist, the patient may still opt for methotrexate treatment but should be informed about the potential reduced efficacy of this approach.
For contraindications that are present, surgical management options include salpingectomy, which involves removing the entire fallopian tube, or salpingostomy, which entails removing only the ectopic pregnancy. Both procedures can be performed laparoscopically. If you choose salpingostomy, it’s crucial to monitor the hCG levels until they return to non-pregnancy levels postoperatively. Additionally, if the patient is Rh-negative, don't forget to administer Rh immune globulin.
If there are no contraindications to methotrexate, you can discuss both medical and surgical management options with the patient, allowing them to make an informed decision on how to proceed. If the patient opts for medical management, methotrexate can be administered using one of three dosing regimens: single, two-dose, or fixed multi-dose intramuscular injections. The single-dose regimen is often preferred for its simplicity and safety. Importantly, the dosage is calculated based on body surface area, not BMI. Also, ensure to administer Rh immune globulin if the patient is Rh-negative.
Here’s a clinical pearl: Advise the patient to avoid folic acid supplements and NSAIDs while taking methotrexate. Folic acid can reduce the efficacy of methotrexate, while NSAIDs may decrease methotrexate clearance, increasing the risk of toxicity. Moreover, patients should be advised to delay their next pregnancy for at least 3 months due to the teratogenic effects of methotrexate.
To monitor the effectiveness of methotrexate, repeat hCG tests are necessary. The frequency of these tests depends on the chosen regimen. For instance, with the single-dose regimen, hCG levels should be checked on days 4 and 7 post-administration, and a decrease of at least 15% indicates successful treatment. The objective is to reduce hCG levels to non-pregnancy levels.
If hCG levels plateau or rise during follow-up, consider administering a second dose of methotrexate and recheck the hCG levels. If there is insufficient decline after the second dose, this is indicative of failed medical management, necessitating surgical intervention. Alternatively, if the patient initially chooses surgical management, procedures such as laparoscopic salpingectomy or salpingostomy can be performed. Remember to administer Rh immune globulin if the patient is Rh-negative.
To summarize: An ectopic pregnancy occurs when a pregnancy develops outside of the uterine cavity. For unstable patients, immediate aggressive fluid resuscitation and potential blood transfusions are necessary, along with plans for urgent surgical intervention. Stable patients should be evaluated using hCG levels and ultrasound to confirm the location and condition of the pregnancy. Management of ectopic pregnancy can be either medical or surgical, depending on the presence of any contraindications and the patient's preferences. Medical management typically involves the administration of methotrexate, while surgical options include salpingectomy or salpingostomy, both of which can be done laparoscopically. Importantly, all Rh-negative patients must receive Rh immune globulin to prevent sensitization.

 - - - - - - -  END - - - - - - - 


作者:Joy,

澳洲最佳高校非首席脑科学科学家/博导,

德国精英大学非精英医学博士,

欢迎合作让我们一起成为首席和精英:

MRYIXUEYANJIU666

请加上述微信进博士职位申请交流群,

欢迎前往公众号菜单栏查阅更多内容,

常用科研技能集锦,

零基础入门R语言,

医学生申请出国读博教程,

GraphPad Prism使用教程,

Image J使用教程,

好书推(请加上述微信进购书/购物优惠群

医学研究笔记
医学博士分享医学与科研相关知识与经验,助力您的医学与科研。
 最新文章